Is hormone therapy tied to lower brain SVD?
-
By
-
Andrea Surnit
-
November 18, 2026
-
4 min
Clinical Scorecard: Is hormone therapy tied to lower brain SVD?
At a Glance
| Category | Detail |
|---|---|
| Condition | Cerebral small vessel disease (SVD) burden and white matter integrity in cognitively unimpaired older women |
| Key Mechanisms | The study examined associations of reproductive lifespan, oral contraceptive use, and menopausal hormone therapy (MHT) with MRI measures of SVD and white matter integrity; it did not establish causal mechanisms. |
| Target Population | 352 women in the Gothenburg H70-1944 Birth Cohort in Sweden, imaged at a mean age of 70.8 years; 205 had repeat imaging about 5 years later. |
| Care Setting | Observational brain MRI research; the findings were described by the authors as contributing to mechanistic understanding rather than immediate clinical translation. |
Key Highlights
- MHT use was associated with 59% lower odds of at least 2 SVD markers and greater white matter integrity; both associations remained significant after multiple-comparison correction.
- Each additional year of reproductive lifespan was associated with 8% lower odds of at least 2 SVD markers, but this association did not remain significant after correction; later menopause accounted for the association in further analyses.
- Women reporting both OC and MHT use had 69% lower odds of at least 2 SVD markers and greater white matter integrity than women reporting neither; both associations remained significant after correction.
- No statistically significant multiplicative interaction between OC and MHT use was found.
- Longitudinal analyses found no significant associations between reproductive lifespan or hormone therapy use and changes in cortical thickness or white matter hyperintensity volume over about 5 years.
Guideline-Based Recommendations
Diagnosis
- The study assessed SVD burden using white matter hyperintensities, lacunes, cerebral microbleeds, and enlarged perivascular spaces on MRI.
- White matter integrity was assessed using fractional anisotropy derived from diffusion tensor imaging.
Management
- The study does not provide treatment recommendations; its authors stated that the findings should not be interpreted as immediate clinical translation.
Monitoring & Follow-up
- Repeat MRI was available for 205 participants about 5 years after baseline imaging.
- No statistically significant associations were found between reproductive lifespan or hormone therapy use and longitudinal changes in cortical thickness or white matter hyperintensity volume.
Risks
- The observational design cannot establish causality or determine whether imaging differences translate into cognitive benefits.
- Hormonal histories were retrospective and self-reported, with limited information on treatment formulation, dose, route, duration, and timing.
- The small longitudinal imaging sample and follow-up attrition may have reduced the ability to detect associations; findings may not generalize beyond cognitively unimpaired older Swedish women.
Patient & Prescribing Data
Cognitively unimpaired older women in a Swedish birth cohort; mean age at baseline MRI was 70.8 years.
Self-reported MHT use was associated with lower odds of multiple SVD markers and greater white matter integrity. The study does not establish causality or support prescribing conclusions.
Clinical Best Practices
- Interpret the reported hormone exposure associations as observational findings, not evidence of a causal treatment effect.
- Do not infer cognitive benefit from the imaging associations; the study found no significant overall associations with Alzheimer's disease-related cortical thickness or abnormal cerebrospinal fluid biomarkers.
- Consider the study's limited treatment-history detail and population when assessing applicability to other patients.
Related Resources & Content
Based on findings from:
Is hormone therapy tied to lower brain SVD?
Andrea Surnit. MDSpire News, 2026.
https://news.mdspire.com/endocrinology/articles/is-hormone-therapy-tied-to-lower-brain-svd/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.